Ionis Pharmaceuticals (IONS) Revenue (2009 - 2026)
Ionis Pharmaceuticals (IONS) posted quarterly Revenue of $267.9 million for Q2 2026, down 40.73% year-over-year from $452.0 million in Q2 2025, and up 435.9% quarter-over-quarter from $50.0 million in Q1 2026.
Ionis Pharmaceuticals (IONS) Revenue (2009 - 2026) Analysis & Trends
Ionis Pharmaceuticals' Revenue history runs 18 years deep, the most recent figure standing at $267.9 million for Q2 2026.
- In Q2 2026, Revenue fell 40.73% year-over-year to $267.9 million; the TTM figure through Jun 2026 stood at $678.0 million (down 28.18% YoY), while the FY2025 annual figure was $943.7 million, up 33.83% from the prior year.
- Revenue for Q2 2026 stood at $267.9 million, up from $50.0 million in the prior quarter.
- The five-year high for Revenue was $452.0 million in Q2 2025, with the low at $50.0 million in Q1 2026.
- The 5-year median for Revenue is $154.3 million (2022), against an average of $185.7 million.
- The sharpest annual moves came in 2022 and 2023: Revenue tumbled 65.48% in 2022, then surged 113.64% in 2023.
- Ionis Pharmaceuticals' Revenue stood at $151.9 million in 2022, then surged by 113.64% to $324.5 million in 2023, then sank by 30.18% to $226.6 million in 2024, then dropped by 10.26% to $203.3 million in 2025, then surged by 31.78% to $267.9 million in 2026.
- Business Quant data shows IONS's Revenue at $267.9 million in Q2 2026, $50.0 million in Q1 2026, and $203.3 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.56 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.71 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3,001.92 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 674.14 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.29 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 425.49 Mn |
| 10 | Ionis Pharmaceuticals | 9.48 Bn | 7.43 Bn | 265.21 Mn | 267.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 267.95 Mn |
| Mar 31, 2026 | 50.00 Mn |
| Dec 31, 2025 | 203.33 Mn |
| Sep 30, 2025 | 156.72 Mn |
| Jun 30, 2025 | 452.05 Mn |
| Mar 31, 2025 | 131.61 Mn |
| Dec 31, 2024 | 226.58 Mn |
| Sep 30, 2024 | 133.81 Mn |
| Jun 30, 2024 | 225.25 Mn |
| Mar 31, 2024 | 119.50 Mn |
| Dec 31, 2023 | 324.51 Mn |
| Sep 30, 2023 | 144.21 Mn |
| Jun 30, 2023 | 188.41 Mn |
| Mar 31, 2023 | 130.52 Mn |
| Dec 31, 2022 | 151.89 Mn |
| Sep 30, 2022 | 159.77 Mn |
| Jun 30, 2022 | 133.79 Mn |
| Mar 31, 2022 | 141.92 Mn |
| Dec 31, 2021 | 440.01 Mn |
| Sep 30, 2021 | 133.09 Mn |